Renalytix (RNLX) Stock Forecast and Price Target 2025 - MarketBeat
2024-05-11 • Google News
Renalytix AI (RNLX)
US$ 0.830.56%
Price Chart
Key Statistics
Market Cap
$ 22.55M
P/E Ratio
0.00
Revenue (TTM)
$ 2.29M
Volume
211.22K
52W High
$ 0.89
52W Low
$ 0.12
Dividend Yield
0.00%
Beta
2.10
Technicals
50-Day MA
0.2695
200-Day MA
0.5102
52 Week High
0.89
52 Week Low
0.12
About RNLX
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence.
Employees
N/A
Headquarters
New York, NY
CEO
Mr. James R. McCullough M.B.A.
Latest News
Autonomous multicolor bioluminescence imaging in bacteria, mammalian, and plant hosts - PNAS
2024-10-02 • Google News
5 Hot Penny Stock On the Move - Insider Monkey
2024-02-22 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg